| 23 May, 11:03 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on May 23, 2026. | nse |
| 23 May, 10:45 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about General Updates | nse |
| 23 May, 10:37 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Public Announcement In Relation To Open Offer To Public Shareholders (As Defined Under Public Announcement) Of The Company Under SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 | bse |
| 21 May, 08:10 am | — | … | Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 12 May, 11:08 pm | — | … | Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 12 May, 10:59 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 12 May, 10:58 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about change in Management | nse |
| 12 May, 10:56 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange that the Board has approved the Final Dividend for the FY 2025-2026. | nse |
| 12 May, 10:50 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Corporate Action-Board approves Dividend | bse |
| 12 May, 10:42 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about Grant of Options under Bliss GVS Pharma Limited Employee Stock Options Plan 2019 | nse |
| 12 May, 10:32 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended March 31, 2026 | bse |
| 12 May, 10:23 pm | — | … | Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 12 May, 10:17 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, May 12, 2026 | bse |
| 05 May, 06:19 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended March 31, 2026 And Recommendation Of Final Dividend If Any, For The Year Ended March 31, 2026. | bse |
| 08 Apr, 04:20 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 08 Apr, 04:11 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about Credit Rating- New rating received from ICRA Limited | nse |
| 03 Apr, 06:58 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 03 Apr, 06:54 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Outcome Of The Circular Resolution Passed By The Board Of Directors | bse |
| 03 Apr, 06:42 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Appointment of Mr Deepak Rameshchandra Shah as Non- Executive Independent Director of the company w.e.f. April 03, 2026. | nse |
| 03 Apr, 06:42 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Appointment of Mr Mr. Vijayanarayanan Mahadevan as Non- Executive Independent Director of the company w.e.f. April 03, 2026. | nse |
| 03 Apr, 06:38 pm | — | … | We would like to inform you that, based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has approved and passed the resolutions by circulation on April 03, 2026 as enclosed. | nse |
| 17 Feb, 07:48 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about the communication to the shareholders regarding tax deduction on the interim dividend declared on February 10, 2026. | nse |
| 13 Feb, 11:22 am | — | … | Bliss GVS Pharma Limited has informed the Exchange about Rumour Verification - Regulation 30(11) | nse |
| 13 Feb, 11:12 am | — | … | Bliss GVS Pharma Ltd - 506197 - Clarification On News Item Appearing In 'CNBC ?????' On February 13, 2026 | bse |
| 12 Feb, 07:15 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Appointment of Mr. Pralay Roy as Other of the company w.e.f. February 12, 2026. | nse |
| 12 Feb, 07:05 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 10 Feb, 06:25 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Resignation of Mrs Vibha Gagan Sharma as Executive Director of the company w.e.f. close of business hours of February 10, 2026. | nse |
| 10 Feb, 06:25 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Resignation of Mrs Shruti Vishal Rao as Executive Director of the company w.e.f. close of business of February 10, 2026. | nse |
| 10 Feb, 06:20 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 10 Feb, 05:10 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Feb-2026. | nse |
| 10 Feb, 05:08 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding 'Grant of Options under Bliss GVS Pharma Limited Employee Stock Options Plan 2019'. | nse |
| 10 Feb, 05:05 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding the contact details of KMPs for reporting of Material Events to Stock Exchanges. | nse |
| 10 Feb, 05:00 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Corporate Action-Board approves Dividend | bse |
| 10 Feb, 03:22 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Outcome Of Board Meeting Held On Tuesday, February 10, 2026 | bse |
| 10 Feb, 03:11 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange that Board of Directors at its meeting held on February 10, 2026, declared Interim Dividend of Rs. 0.50 per equity share. | nse |
| 10 Feb, 03:08 pm | — | … | The Board Meeting of Bliss GVS Pharma Limited ( the Company ) was held today i.e. Tuesday, February 10, 2026, at the registered office has considered and approved the following matter(s) amongst others:1. Approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025. A copy of unaudited Standalone and Consolidated Financial Results of the Company, along with the Limited Review Report of the Auditors of the Company for | nse |
| 10 Feb, 03:02 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange that Board of Directors at its meeting held on February 10, 2026, declared Interim Dividend of 0.50 per equity share. | nse |
| 03 Feb, 06:27 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for The Meeting Board Of Directors Of The Company Is Scheduled To Be Held On Tuesday, February 10, 2026. | bse |
| 27 Jan, 06:37 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding 'Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Bliss GVS International PTE Ltd , Singapore, a wholly owned subsidiary of Bliss GVS Pharma Limited ( the Company ), has incorporated a wholly owned subsidiary namely THERALIFE PHARMA RDC PRIVATE LIMITED , Kinshasa Gombe, Democratic Republic of the Congo'. | nse |
| 23 Dec, 04:46 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Appointment of Mr Narsimha Shibroor Kamath as Managing Director & CEO of the company w.e.f. December 23, 2025. | nse |
| 23 Dec, 04:36 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 23 Dec, 02:07 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, December 23, 2025 | bse |
| 23 Dec, 02:00 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Board meeting held on December 23, 2025. | nse |
| 09 Dec, 05:12 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 66380 securities pursuant to ESOP/ESPS at its meeting held on December 09, 2025 | nse |
| 25 Nov, 08:06 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange that Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Bliss GVS International PTE Ltd , Singapore, a wholly owned subsidiary of Bliss GVS Pharma Limited ( the Company ), has incorporated a wholly owned subsidiary namely Theralife Pharma Ltd , Nairobi, Kenya. | nse |
| 06 Nov, 09:41 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange about the Grant of Options under Bliss GVS Pharma Limited Employee Stock Options Plan 2019 | nse |
| 06 Nov, 09:18 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding details of KMPs for disclosure of Material Events to Stock Exchanges | nse |
| 06 Nov, 09:12 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 06 Nov, 09:11 pm | — | … | Bliss GVS Pharma Limited has informed the Exchange regarding Resignation of Mr Gagan Harsh Sharma as Managing Director of the company w.e.f. November 06, 2025. | nse |
| 06 Nov, 09:03 pm | — | … | Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Management | bse |